EU dispatches Hantavirus samples to European nations
The European Union announced the shipment of the first batch of an experimental drug against the Hantavirus to France, Spain, and the Netherlands, in an effort to contain the spread of the disease and treat recorded cases. A total of 1,400 samples of the drug "Favipiravir" have been provided, following a donation from a Japanese company affiliated with Fujifilm. This medication is currently one of the main solutions in use, as there are no fully approved vaccines or treatments against Hantavirus yet. Each country will assess the use of the drug based on health status and need, while also initiating procedures to purchase additional quantities in anticipation of an increase in cases in the coming weeks.
Notice: This Is an AI-Generated Summary
Comments (0)